Antrodia salmonea inhibits TNF-α-induced angiogenesis and atherogenesis in human endothelial cells through the down-regulation of NF-κB and up-regulation of Nrf2 signaling pathways

J Ethnopharmacol. 2014;151(1):394-406. doi: 10.1016/j.jep.2013.10.052. Epub 2013 Nov 6.

Abstract

Ethnopharmacological relevance: Antrodia salmonea (AS) is known as a traditional Chinese medicine, but very few biological activities have been reported.

Materials and methods: The present study was aimed to investigate the anti-angiogenic and anti-atherosclerotic potential of the fermented culture broth of AS against tumor necrosis factor-α (TNF-α)-stimulated human endothelial (EA.hy 926) cells.

Results: The non-cytotoxic concentrations of AS significantly inhibited TNF-α-induced migration/invasion and capillary-like tube formation in EA.hy 926 cells. Furthermore, AS suppressed TNF-α-induced activity and expression of matrix metalloproteinase-9 (MMP-9), and cell-surface expression of intercellular adhesion molecule-1 (ICAM-1), which was associated with abridged adhesion of U937 leukocytes to endothelial cells. Moreover, AS significantly down-regulated TNF-α-induced nuclear translocation and transcriptional activation of nuclear factor κB (NF-κB) followed by suppression of I-κB degradation and phosphorylation of I-κB kinase-α (IKKα). Notably, the protective effect of AS was directly correlated with the increased expression of hemeoxygenase-1 (HO-1) and γ-glutamylcysteine synthetase (γ-GCLC), which was reasoned by nuclear translocation and transactivation of NF-E2 related factor-2 (Nrf2)/antioxidant response element (ARE). Furthermore, HO-1 knockdown by HO-1-specific shRNA diminished the protective effects of AS on TNF-α-stimulated invasion, tube formation, and U937 adhesion in EA.hy 926 cells.

Conclusions: Taken together, these results suggest that Antrodia salmonea may be useful for the prevention of angiogenesis and atherosclerosis.

Keywords: ARE; AS; Antrodia salmonea; DMEM; Dulbecco's Modified Eagle's medium; EA.hy 926 cells; FBS; FITC; GSH; HO-1; Hemeoxygenase-1; I-κB; I-κB kinase-α; ICAM-1; IKKα; MMP-9; NF-κB; Nrf2; PBS; TNF-α; antioxidant response element; fetal bovine serum; fluorescein isothiocyanate; glutathione; inhibitor-κB; intercellular adhesion molecule-1; matrix metalloproteinase-9; nuclear factor erythroid 2-related factor 2; nuclear factor-κB; phosphate buffer saline; tumor necrosis factor-α; γ-GCLC; γ-glutamylcysteine synthetase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antrodia / chemistry*
  • Atherosclerosis / drug therapy
  • Cell Adhesion
  • Cell Survival
  • Down-Regulation
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism
  • Gene Knockdown Techniques
  • Glutamate-Cysteine Ligase / genetics
  • Glutamate-Cysteine Ligase / metabolism
  • Heme Oxygenase-1 / genetics
  • Heme Oxygenase-1 / metabolism
  • Humans
  • Intercellular Adhesion Molecule-1 / genetics
  • Intercellular Adhesion Molecule-1 / metabolism
  • Matrix Metalloproteinase 9 / genetics
  • Matrix Metalloproteinase 9 / metabolism
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism*
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Neovascularization, Physiologic / drug effects
  • Tumor Necrosis Factor-alpha / pharmacology*
  • U937 Cells
  • Up-Regulation

Substances

  • NF-E2-Related Factor 2
  • NF-kappa B
  • NFE2L2 protein, human
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • HMOX1 protein, human
  • Heme Oxygenase-1
  • Matrix Metalloproteinase 9
  • Glutamate-Cysteine Ligase